Company Profile LogoCylene Pharmaceuticals

Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.

Edit IconSuggest an Edit
Pharmaceutical
Health Care
Biotechnology

    Unlock insights on Cylene Pharmaceuticals and 2M+ companies now!

    About Cylene Pharmaceuticals

    Cylene Pharmaceuticals, Inc., a biotech pharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs that target nucleolus and kill cancer cells. It offers nucleolus targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors; and serine/threonine protein kinase inhibitors. The company also provides pre-clinical stage oral drug candidates. Cylene Pharmaceuticals, Inc.

    Company Highlights
    Year Founded

    2001

    icon-altEmployees

    2

    Location (HQ)

    USA

    Since Last Funding

    11 years 7 months

    icon-altTotal Investment Amt

    $100M

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Biotechnology

    Biotechnology Research

    Pharmaceutical